Resting metabolic signature of non-alcoholic fatty liver disease and the metabolic response to acute exercise in a community based sample07/01/2019 - 06/30/2022 (PI)
Doris Duke Charitable Foundation
Prevalence and risk factors for hepatic steatosis and fibrosis as measured by transient elastography03/15/2016 - 05/31/2019 (PI)
Echosens
Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the…01/12/2018 - 11/30/2022 (PI)
NIH-NIDDK5K23DK113252-03
AURORA: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study07/01/2019 - 07/31/2022 (PI)
Allergan Sales, LLC
MB130-06812/06/2018 - 12/06/2021 (PI)
Bristol-Myers
MB130-06912/06/2018 - 12/06/2021 (PI)
Bristol-Myers
Determining the burden, heritability, and clinical implications of increased liver stiffness from…01/02/2019 - 01/01/2021 (PI)
Gilead Sciences
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating …05/16/2017 - 05/16/2020 (PI)
Intercept Pharmaceuticals, Inc.
A Double-Blind, Placebo-Controlled Trial of Obeticholic Acid in Patients with moderately severe A…10/06/2016 - 10/05/2018 (PI)
Indiana University NIH-NIAAA4U01AA021840-05